The Association Between Serum Resistin Level with the Degree of Coronary Artery Stenosis


Coronary artery stenosis is a thickening of intimal coronary artery due to chronic inflammation of blood vessels, characterized by the accumulation of inflammatory cells, vascular smooth muscle cells, lipid, and fibrotic tissue. Resistin, a cysteine-rich secretory protein, produced by monocytes and adipose cells, increases proinflammatory cytokines. This study was conducted to analyze the association between serum resistin level with the severity of coronary artery stenosis. This cross-sectional study was performed in 60 patients aged 30-70 years old who were suspected to have coronary heart disease (CHD) and underwent coronary angiography at Cardiology Department of Dr. Moewardi Hospital in Surakarta. The cutoff point of serum resistin level was
determined by receiver operating curve (ROC). The data were analyzed to determine the prevalence ratio of each variable, followed by logistic regression, p<0.05 was considered statistically significant. This study found a significant association between serum resistin level and the severity of coronary artery stenosis. At the cutoff point of 6.37 ng/ml, bivariate and multivariate analysis showed that resistin had the prevalence ratio (PR) of 6.56 (95% CI: 1.705-25.263; p = 0.005) and 7.47 (95% CI: 1.562-35.784; p = 0.012), respectively. Even after adjustment with body mass index, sex, hypertension, dyslipidemia and type 2 DM, resistin showed significant association with the severity of coronary artery stenosis (PR: 7.48; 95% CI: 1.562-35.784; p = 0,012).

Keywords: coronary artery stenosis, resistin

[1] World Health Organization (WHO) 2016 Cardiovascular Diseases (CVDs). http://www.

[2] DEPKES 2008 Good Laboratory Practice ( Jakarta, Departemen Kesehatan) p 95-104

[3] Gotlieb AI 2007 Cardiovasc. Pathol. 14 181-84

[4] Raman G, Yu W, Ip S, Salvi P, Chang L K W, Iovin R C, Rao M, et al 2013 Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting AHRQ Publication No. 13-EHC055-EF Rockville.

[5] Costigan J, Elias R, Jickling J, Mac Iver M, Moon H, Morris N, Polinger D N, et al 2014 Coronary artery diseases basic.

[6] Marzilli M, Mersz N B, Boden W E, Bonow R O, Capozza P G, Chilian M W, de Maria A N, et al, 2012 JACC 60 (11) 951-56

[7] Tavakol M, Ashraf A and Brener S. GJHS 4 (1) 65-77

[8] Bhatt S, Tandon A and Bhargawa S 2013 JIMSA 26 (1) 31-34

[9] Libby P, 2005 Atherosclerosis: The New View (New York: Scientic American. Inc) p 47-55

[10] La Morte W W, 2016 A therosclerosis (Boston: Boston University School of Public Health).

[11] Yaseen F 2014 Pak. J. Med. Dent. 3 (1) 17-22

[12] de Leon AC, Gonzalez DA, Hernandez A G, Coella S D, Marrugat J, Sanchez J J, Diaz B B, et al 2014 J. Atheroscler. Thromb. 21 1-9

[13] Reilly M P, Lehrke M, Wolfe ML, Rohalgi A, Lazar M A and Rader D J 2005 Circulation 111 932-39

[14] Cho Y, Lee S, Lee H C, Hur J, Lee S, Youn S W, Lee J et al 2011 JACC 57 99-109

[15] Bashore T M, Balter S, Barac A, Byrne J G, Cavendish J J, Chambers C E, Hermiller Jr J B, et al 2012 Catheter. Cardiovasc. Interv. 80 E37-E49

[16] Krecki R, Drozdz J, Szczesniak P, Orszulak-Michalak D and Krzeminska-Pakula M 2008 Kardiol.Pol. 66 (11) 1173-80

[17] Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, Ayaori M, Nakamura H and Ohsuzu F 2005 JACC 46 (2) 379-82

[18] Mortavazi R, Kazeroni A R, Ostovan A M, Omrani GR, Shams M, et al 2017 Int. Cardiovasc. Res. J. 11 (1) 7-12

[19] Kelley R E, DasMahapatra P, Wang J, Chen W, Srinivasan S, Fernandez C, Xu J, et al 2011 South. Med. J. 104 (12) 803-08

[20] Rossi R, Laccarino D, Chiurlia E, Nuzzo D, Venturelli A and Modena A G 2011 Nutr. Metab. Cardiovasc. Dis. 21 (2) 86-89

[21] Pelt R E, Evans E M, Schectman K B, Ehsani A A and Kohrt WM 2001 Int. J. Obes. 25 1183-88

[22] Chang Y, Yun K E, Jung H S, Kim C W, Kwon E S and Ryu S. 2013 Arterioscler. Thromb. Vasc. Biol. 33: 2026-31